Technology | August 23, 2012

Philips Becomes Exclusive Distributor of Corindus’ Robotic Interventional Cardiology System

CorPath 200 system is the world’s first robotic-assisted system for the minimally invasive treatment of obstructed coronary arteries

August 23, 2012  Philips Healthcare and Corindus Vascular Robotics announced a distribution agreement for Corindus’ CorPath 200 System. The system was recently cleared by the U.S. Food and Drug Administration (FDA) and is the world's first robotic-assisted system for percutaneous coronary intervention (PCI) of obstructed coronary arteries.

The financial details of the exclusive distribution agreement were not disclosed. Philips owns a minority share in Corindus Vascular Robotics.

The CorPath 200 can be integrated with all major X-ray fluoroscopy systems, including Philips’ Allura X-ray equipment. The robotic-assisted system is a compact and cost-efficient system that can be used with standard stents, catheters and guidewires. The distribution agreement enables both companies to sell this unique robotic-assisted system in the United States, addressing an immediate need of patients, interventional cardiologists and staff. This agreement is the next step in the alliance between Philips and Corindus, which was announced in 2011.

“Robotic-assisted interventional technologies have great potential to further improve current image-guided minimally invasive procedures, which is a fast growing market with, for example, more than 1 million PCI procedures estimated to be performed in the United States in 2012,” said Gene Saragnese, CEO of imaging systems at Philips Healthcare. “By teaming up with partners with complementary and unique strengths, such as Corindus Vascular Robotics, we aim to shape the future of healthcare by delivering innovative solutions that enhance clinical capabilities, improve patient outcomes and reduce healthcare costs.”

X-ray fluoroscopy is generally accepted as the most suitable imaging technology for accurately visualizing the progress of the catheter and other interventional tools during the minimally invasive treatment of cardiac conditions. However, since interventional cardiologists perform many PCI procedures, over time clinical data has demonstrated that this can lead to health and orthopedic problems.

The CorPath 200 system has been designed for the robotic-assisted placement of the coronary guidewires and stent/balloon catheters used in PCI procedures. It is operated by the interventional cardiologist from a radiation-shielded, interventional cockpit. Additionally, the seated position in front of monitors may provide enhanced measurement and view of the angiography screen, while reducing fatigue and head, neck and back strain.

“At Northeast Georgia Medical Center, our group performs more than 2,000 procedures a year,” said Jeffrey Marshall, M.D., of the Northeast Georgia Heart Center. “Some of them lasting more than four hours – standing hunched over a bed and wearing a heavy lead apron. Robotic-assisted PCI allows us to perform the procedure shielded from radiation while precisely controlling the coronary guidewires and stent/balloon catheters. The CorPath 200 system may enhance precision and control of stent and guidewire positioning, which ultimately can potentially enhance patient care.”

The CorPath PRECISE Trial, a prospective, single-arm, multicenter study, which enrolled 164 patients and was submitted to FDA as part of system’s approval process, demonstrated robotic-assisted PCI is safe and feasible for patients. It also showed it can also significantly reduce radiation exposure for the interventional cardiologist.

“We are excited to have a strong partner in Philips, who has such an established reputation and presence in interventional cardiology,” said David Handler, president and CEO of Corindus. “Philips’ U.S. sales force has already been introduced to the CorPath 200 System, and U.S. commercialization is underway. Additionally, Corindus Vascular Robotics is also bolstering our U.S. sales force to provide clinical support to interventional cardiologists performing robotic-assisted PCI.”

For more information: www.philips.com/newscenter, www.corindus.com

Related Content

Montreal Heart Institute Performs First Robotic Mitral Valve Surgery
News | Robotic Systems| September 22, 2017
The Montreal Heart Institute (MHI) announced the acquisition of the da Vinci Xi, a new-generation surgical robot, and...
Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Overlay Init